PEB - Pacific Edge Ltd

[Minerbarejet]

It would appear that PEB sales are increasing overall based on the last three half years at a rate of about 1m per half in a covid affected environment.
If this continued at the current rate sales for this half should be at least 6.3 giving a total for the year of around 12m.

3326 31 Sep 2020
4375 31 Mar 2021
7701 FY

5378 31 Sep 2021
6380 31 Mar 2022 ( projected)
11758 FY

If they do better than that then the rate is climbing and will reflect the larger sales force at work.

[Mel]

Announcement of a new clinical study
https://www.nzx.com/announcements/391797

[Mel]

Announcement of a new clinical study
https://www.nzx.com/announcements/391797

Reiteration that "“Cxbladder already has substantial adoption for detection and surveillance of urothelial cancer with more than 2,000 urologists using the test in the workup of more than 80,000 patients.” The definition of 'workup' and any resultant assumptions makes revenue forecasting a little challenging......I guess we'll have to wait for their results announcement. This is positive news nonetheless.

[Minerbarejet]

Reiteration that "“Cxbladder already has substantial adoption for detection and surveillance of urothelial cancer with more than 2,000 urologists using the test in the workup of more than 80,000 patients.” The definition of 'workup' and any resultant assumptions makes revenue forecasting a little challenging......I guess we'll have to wait for their results announcement. This is positive news nonetheless.

Further reflection on the 2000/80,000 statement gives me the impression it is probably an accumulative total in both areas over several years.

[Maxtrade]

Lets hope 0.83 holds otherwise charts indicating a slippery downwards retracement from there! Maybe the optimists here can keep buying and help hold the line. Probably cant withstand too much more downwards pressure until something breaks here though.

Disappointing support broke through 0.83, highly likely back down into the 0.7's next. Those that bought in last Cap Raise probably starting to cringe if they haven't already sold out - might well have by now. See where it bottoms, stabilises and maybe buy back in then, if there is any aligning supportive updates with real impact figures. Will be hard to rally in a globally weak general market outlook. Higher growth stocks, tech, speculative are proving to get hit the hardest.
How low do investors here tend to think SP will need to go before a support level can form. Hopefully it's not going to retrace to 0.62 support level on the charts!!? Ouch!

[850man]

Disappointing support broke through 0.83, highly likely back down into the 0.7's next. Those that bought in last Cap Raise probably starting to cringe if they haven't already sold out - might well have by now. See where it bottoms, stabilises and maybe buy back in then, if there is any aligning supportive updates with real impact figures. Will be hard to rally in a globally weak general market outlook. Higher growth stocks, tech, speculative are proving to get hit the hardest.
How low do investors here tend to think SP will need to go before a support level can form. Hopefully it's not going to retrace to 0.62 support level on the charts!!? Ouch!

The lack of any concrete results has not helped with confidence in the company. I'm damn sure all those who participated in the cap raise at $1.32 have not been left with a good taste in their mouths. At least 6 months ago, they hired a bunch of sales people in the USA. If I was running that shop, I'd be expecting some real results and revenue in hand from them by now. It's not just buying coffees and lunches.

[Minerbarejet]

Announcement of a new clinical study
https://www.nzx.com/announcements/391797

Interesting to note the timing of this announcement just prior to the AUA conference being held on the 13th to 16th of May.
Its sort of like one across the bows of AUA. Sit up and take notice.

800,000 patients is the usual number of patients bandied about for recurrence monitoring in the USA at any given point.
It could possibly become standard of care after a couple of clear cystoscopies requiring a cxbladder regimen of tests every few months for 5 years or until declared in remission.

[Sideshow Bob]

Anything speculative is getting its bum smacked in the current environment.

PEB has a market cap today at $656m, and revenue in the past 6 months of about 1% of that. Still plenty of cash in the bank, but ultimately need to see sales/tests/revenue - hasn't happened has it? Their FY due in just over 2 weeks will be telling, and would say there would need to be real development.

Chief Cheerleader has left the building, so whether it was a hospital pass, or on the cusp of greatness, it remains to be seen. After 20+ years, probably not the latter......

[winner69]

.....................

Chief Cheerleader has left the building, so whether it was a hospital pass, or on the cusp of greatness, it remains to be seen. After 20+ years, probably not the latter......

.... and the troupe of cheerleaders went with him .... no glamour left

I see share price down in 30's again ,,,, and they'll still be hanging in there .... unless they decide to toss in the towel and say it's not worth it

[Sideshow Bob]

.... and the troupe of cheerleaders went with him .... no glamour left

I see share price down in 30's again ,,,, and they'll still be hanging in there .... unless they decide to toss in the towel and say it's not worth it

They do have about $105m in cash as at last report, so that is about 15cps.

Plenty to go before they toss the towel....